Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Patient MonitoringIn Vitro DiagnosticsBlood Glucose Monitoring

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1563890

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1563890

Continuous Glucose Monitoring Systems

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Continuous Glucose Monitoring Systems Market to Reach US$10.3 Billion by 2030

The global market for Continuous Glucose Monitoring Systems estimated at US$3.6 Billion in the year 2023, is expected to reach US$10.3 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2023-2030. Sensors Component, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the Transmitters & Receivers Component segment is estimated at 16.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$965.1 Million While China is Forecast to Grow at 22.5% CAGR

The Continuous Glucose Monitoring Systems market in the U.S. is estimated at US$965.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.8 Billion by the year 2030 trailing a CAGR of 22.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.2% and 13.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Global Continuous Glucose Monitoring Systems Market - Key Trends & Drivers Summarized

How Are Continuous Glucose Monitoring Systems Revolutionizing Diabetes Management?

Continuous Glucose Monitoring (CGM) systems are revolutionizing the management of diabetes by providing real-time insights into glucose levels, allowing for better glycemic control and more informed treatment decisions. Unlike traditional finger-prick methods, CGM devices continuously measure glucose levels through a sensor inserted under the skin, offering data that can be accessed via smartphones or dedicated readers. This technological advancement significantly enhances the ability to track blood glucose patterns and trends, enabling patients and healthcare providers to tailor treatment plans more effectively. The convenience and accuracy provided by CGM systems are especially crucial for patients with Type 1 diabetes, who require precise insulin dosing. Furthermore, the increasing prevalence of diabetes globally, driven by factors such as aging populations, sedentary lifestyles, and rising obesity rates, is amplifying the demand for these advanced monitoring systems.

What Technological Innovations Are Shaping The Future Of CGM Devices?

The Continuous Glucose Monitoring systems market is being propelled by several technological innovations that are enhancing device accuracy, user experience, and data analytics capabilities. The development of smaller, more comfortable sensors that provide longer wear times and require fewer calibrations is significantly improving patient adherence and satisfaction. Next-generation CGM systems are integrating with insulin pumps, creating closed-loop systems or “artificial pancreas” setups that automate insulin delivery based on real-time glucose readings. Advances in Bluetooth technology and smartphone app integrations are allowing users to easily share their glucose data with caregivers and healthcare providers, promoting better diabetes management. Furthermore, predictive analytics and AI-based algorithms are being employed to forecast potential glucose level trends, providing alerts to prevent hyperglycemia or hypoglycemia. These technological advancements are not only enhancing the effectiveness of CGM systems but are also making diabetes management more proactive and personalized.

How Are Regulatory Approvals And Reimbursement Policies Impacting The CGM Market?

Regulatory approvals and favorable reimbursement policies are crucial factors driving the expansion of the Continuous Glucose Monitoring systems market. In recent years, regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have fast-tracked approvals for new CGM devices, recognizing their potential to improve patient outcomes and reduce healthcare costs. These regulatory endorsements have instilled greater confidence among healthcare providers and patients regarding the safety and efficacy of CGM systems. Additionally, insurance companies and government healthcare programs in several countries are expanding their coverage for CGM devices, making them more accessible to a larger segment of the diabetic population. The increasing inclusion of CGM systems in health insurance reimbursement plans is a key factor enabling broader adoption and use, particularly among the elderly and those with Type 1 diabetes who require constant monitoring.

What Factors Are Driving The Growth Of The Continuous Glucose Monitoring Systems Market?

The growth in the Continuous Glucose Monitoring systems market is driven by several factors, including rising diabetes prevalence, technological advancements, and supportive regulatory and reimbursement frameworks. One of the key drivers is the increasing awareness among patients and healthcare providers about the benefits of real-time glucose monitoring for achieving better glycemic control. The growing adoption of CGM systems is also being fueled by their integration with digital health platforms and mobile applications, which offer enhanced user engagement and data-driven insights. Additionally, the shift toward value-based care in the healthcare industry is promoting the use of CGM systems as a means to reduce diabetes-related complications and overall healthcare costs. Further driving the market are strategic partnerships between CGM device manufacturers and digital health companies, which are expanding the capabilities of these devices through data analytics and artificial intelligence. These factors collectively contribute to the robust growth outlook for the CGM market worldwide.

Select Competitors (Total 53 Featured) -

  • Biorasis
  • Carbometrics
  • Dexcom, Inc.
  • GlySens, Inc.
  • Medtronic PLC
  • Metronom Health
  • Nemaura Medical, Inc.
  • PharmaSens
  • Quin Technology
  • Senseonics Holdings, Inc.
Show more
Product Code: MCP15797

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Continuous Glucose Monitoring Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Diabetes and Need for Continuous Monitoring
    • Technological Advancements in CGM Device Accuracy and Connectivity
    • Rising Adoption of Wearable Health Monitoring Devices
    • Growing Demand for Non-Invasive Glucose Monitoring Solutions
    • Integration of CGM with Digital Health Platforms and Apps
    • Development of AI-Based Predictive Analysis in Diabetes Management
    • Increasing Awareness and Adoption Among Non-Diabetic Users
    • Expanding Availability of CGM Devices in Emerging Markets
    • Government Reimbursement Policies Supporting CGM Adoption
    • Innovations in Miniaturized and Implantable Glucose Sensors
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Continuous Glucose Monitoring Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Sensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transmitters & Receivers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Transmitters & Receivers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Integrated Insulin Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Integrated Insulin Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinics & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinics & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • JAPAN
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • CHINA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • EUROPE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • FRANCE
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • GERMANY
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • INDIA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Continuous Glucose Monitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030
  • AFRICA
    • Continuous Glucose Monitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Continuous Glucose Monitoring Systems by Component - Sensors, Transmitters & Receivers and Integrated Insulin Pumps Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by Component - Percentage Breakdown of Value Sales for Sensors, Transmitters & Receivers and Integrated Insulin Pumps for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Continuous Glucose Monitoring Systems by End-Use - Clinics & Diagnostic Centers, Home Healthcare and ICUs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Continuous Glucose Monitoring Systems by End-Use - Percentage Breakdown of Value Sales for Clinics & Diagnostic Centers, Home Healthcare and ICUs for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!